経皮パッチ市場は2023年から2028年に20億米ドル、予測期間中のCAGRは5.65％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、非侵襲的ドラッグデリバリー方法に対する需要の高まり、慢性疾患の有病率の増加、経皮パッチ開発への投資増加によるヘルスケア支出の増加によって牽引されています。
本調査では、今後数年間の経皮パッチ市場成長を牽引する主な要因の一つとして、ドラッグデリバリー効率向上のためのマイクロニードルパッチの市場開拓を挙げています。また、経皮パッチの皮膚科学分野や化粧品分野への応用拡大、パッチ製造における持続可能で生分解性のある材料の採用は、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global transdermal patches market 2018 - 2022
4.2 Application Segment Analysis 2018 - 2022
4.3 End User Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Application
6.1 Market segments
6.2 Comparison by Application
6.3 Pain management - Market size and forecast 2023-2028
6.4 Central nervous system disorders - Market size and forecast 2023-2028
6.5 Hormonal application - Market size and forecast 2023-2028
6.6 Cardiovascular diseases - Market size and forecast 2023-2028
6.7 Others - Market size and forecast 2023-2028
6.8 Market opportunity by Application
7 Market Segmentation by End-user
7.1 Market segments
7.2 Comparison by End-user
7.3 Homecare - Market size and forecast 2023-2028
7.4 Hospitals and clinics - Market size and forecast 2023-2028
7.5 Market opportunity by End-user
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 China - Market size and forecast 2023-2028
9.9 Germany - Market size and forecast 2023-2028
9.10 UK - Market size and forecast 2023-2028
9.11 Japan - Market size and forecast 2023-2028
9.12 Market opportunity by geography
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Agile Therapeutics Inc.
12.4 Alvogen Iceland ehf
12.5 Bayer AG
12.6 Boehringer Ingelheim International GmbH
12.7 Endo International Plc
12.8 Hisamitsu Pharmaceutical Co. Inc.
12.9 IontoPatch
12.10 Johnson and Johnson Services Inc.
12.11 Lead Chemical Co. Ltd.
12.12 Luye Pharma Group Ltd.
12.13 Nitto Denko Corp.
12.14 Novartis AG
12.15 Purdue Pharma LP
12.16 Teva Pharmaceutical Industries Ltd.
12.17 Viatris Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global transdermal patches market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End User Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Five forces analysis - Comparison between 2023 and 2028
Exhibits23: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits24: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits25: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits26: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits27: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits28: Chart on Market condition - Five forces 2023 and 2028
Exhibits29: Chart on Application - Market share 2023-2028 (%)
Exhibits30: Data Table on Application - Market share 2023-2028 (%)
Exhibits31: Chart on Comparison by Application
Exhibits32: Data Table on Comparison by Application
Exhibits33: Chart on Pain management - Market size and forecast 2023-2028 ($ billion)
Exhibits34: Data Table on Pain management - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Chart on Pain management - Year-over-year growth 2023-2028 (%)
Exhibits36: Data Table on Pain management - Year-over-year growth 2023-2028 (%)
Exhibits37: Chart on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits38: Data Table on Central nervous system disorders - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Chart on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
Exhibits40: Data Table on Central nervous system disorders - Year-over-year growth 2023-2028 (%)
Exhibits41: Chart on Hormonal application - Market size and forecast 2023-2028 ($ billion)
Exhibits42: Data Table on Hormonal application - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Chart on Hormonal application - Year-over-year growth 2023-2028 (%)
Exhibits44: Data Table on Hormonal application - Year-over-year growth 2023-2028 (%)
Exhibits45: Chart on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits46: Data Table on Cardiovascular diseases - Market size and forecast 2023-2028 ($ billion)
Exhibits47: Chart on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits48: Data Table on Cardiovascular diseases - Year-over-year growth 2023-2028 (%)
Exhibits49: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits51: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits53: Market opportunity by Application ($ billion)
Exhibits54: Data Table on Market opportunity by Application ($ billion)
Exhibits55: Chart on End-user - Market share 2023-2028 (%)
Exhibits56: Data Table on End-user - Market share 2023-2028 (%)
Exhibits57: Chart on Comparison by End-user
Exhibits58: Data Table on Comparison by End-user
Exhibits59: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits60: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Chart on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits62: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits63: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits67: Market opportunity by End-user ($ billion)
Exhibits68: Data Table on Market opportunity by End-user ($ billion)
Exhibits69: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits70: Chart on Market share by geography 2023-2028 (%)
Exhibits71: Data Table on Market share by geography 2023-2028 (%)
Exhibits72: Chart on Geographic comparison
Exhibits73: Data Table on Geographic comparison
Exhibits74: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits75: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits78: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits79: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits82: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits83: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits86: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits87: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits90: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits91: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits94: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits95: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits99: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits102: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits103: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits105: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits106: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits107: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits108: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits109: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits110: Market opportunity by geography ($ billion)
Exhibits111: Data Tables on Market opportunity by geography ($ billion)
Exhibits112: Impact of drivers and challenges in 2023 and 2028
Exhibits113: Overview on Criticality of inputs and Factors of differentiation
Exhibits114: Overview on factors of disruption
Exhibits115: Impact of key risks on business
Exhibits116: Vendors covered
Exhibits117: Matrix on vendor position and classification
Exhibits118: Agile Therapeutics Inc. - Overview
Exhibits119: Agile Therapeutics Inc. - Product / Service
Exhibits120: Agile Therapeutics Inc. - Key offerings
Exhibits121: Alvogen Iceland ehf - Overview
Exhibits122: Alvogen Iceland ehf - Product / Service
Exhibits123: Alvogen Iceland ehf - Key offerings
Exhibits124: Bayer AG - Overview
Exhibits125: Bayer AG - Business segments
Exhibits126: Bayer AG - Key news
Exhibits127: Bayer AG - Key offerings
Exhibits128: Bayer AG - Segment focus
Exhibits129: Boehringer Ingelheim International GmbH - Overview
Exhibits130: Boehringer Ingelheim International GmbH - Business segments
Exhibits131: Boehringer Ingelheim International GmbH - Key news
Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
Exhibits133: Boehringer Ingelheim International GmbH - Segment focus
Exhibits134: Endo International Plc - Overview
Exhibits135: Endo International Plc - Business segments
Exhibits136: Endo International Plc - Key news
Exhibits137: Endo International Plc - Key offerings
Exhibits138: Endo International Plc - Segment focus
Exhibits139: Hisamitsu Pharmaceutical Co. Inc. - Overview
Exhibits140: Hisamitsu Pharmaceutical Co. Inc. - Product / Service
Exhibits141: Hisamitsu Pharmaceutical Co. Inc. - Key offerings
Exhibits142: IontoPatch - Overview
Exhibits143: IontoPatch - Key offerings
Exhibits144: Johnson and Johnson Services Inc. - Overview
Exhibits145: Johnson and Johnson Services Inc. - Business segments
Exhibits146: Johnson and Johnson Services Inc. - Key news
Exhibits147: Johnson and Johnson Services Inc. - Key offerings
Exhibits148: Johnson and Johnson Services Inc. - Segment focus
Exhibits149: Lead Chemical Co. Ltd. - Overview
Exhibits150: Lead Chemical Co. Ltd. - Product / Service
Exhibits151: Lead Chemical Co. Ltd. - Key offerings
Exhibits152: Luye Pharma Group Ltd. - Overview
Exhibits153: Luye Pharma Group Ltd. - Business segments
Exhibits154: Luye Pharma Group Ltd. - Key offerings
Exhibits155: Luye Pharma Group Ltd. - Segment focus
Exhibits156: Nitto Denko Corp. - Overview
Exhibits157: Nitto Denko Corp. - Business segments
Exhibits158: Nitto Denko Corp. - Key offerings
Exhibits159: Nitto Denko Corp. - Segment focus
Exhibits160: Novartis AG - Overview
Exhibits161: Novartis AG - Business segments
Exhibits162: Novartis AG - Key news
Exhibits163: Novartis AG - Key offerings
Exhibits164: Novartis AG - Segment focus
Exhibits165: Purdue Pharma LP - Overview
Exhibits166: Purdue Pharma LP - Product / Service
Exhibits167: Purdue Pharma LP - Key offerings
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: Viatris Inc. - Overview
Exhibits174: Viatris Inc. - Business segments
Exhibits175: Viatris Inc. - Key news
Exhibits176: Viatris Inc. - Key offerings
Exhibits177: Viatris Inc. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations
